Evidence map›Paper›PMID 38858272›Full record

ArticleClinical neuroradiology2024

Radiomics Analysis of Quantitative Maps from Synthetic MRI for Predicting Grades and Molecular Subtypes of Diffuse Gliomas.

Danlin Lin, Jiehong Liu, Chao Ke, Haolin Chen, Jing Li, Yuanyao Xie, Jianhua Ma, Xiaofei Lv, Yanqiu Feng

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical neuroradiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Danlin LinDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.ORCID http://orcid.org/0009-0000-7520-4364
Jiehong LiuSchool of Biomedical Engineering, Southern Medical University, Guangzhou, China.ORCID http://orcid.org/0000-0002-1381-6055
Chao KeDepartment of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.ORCID http://orcid.org/0000-0003-1918-9600
Haolin ChenDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.ORCID http://orcid.org/0000-0003-1791-6560
Jing LiDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.ORCID http://orcid.org/0000-0001-7634-406X
Yuanyao XieSchool of Biomedical Engineering, Southern Medical University, Guangzhou, China.ORCID http://orcid.org/0000-0002-6781-5971
Jianhua MaSchool of Biomedical Engineering, Southern Medical University, Guangzhou, China.ORCID http://orcid.org/0000-0003-2958-1710
Xiaofei LvDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. lvxf@sysucc.org.cn.ORCID http://orcid.org/0000-0002-1712-630X
Yanqiu FengSchool of Biomedical Engineering, Southern Medical University, Guangzhou, China. foree@smu.edu.cn.ORCID http://orcid.org/0000-0002-2807-5974

Funding

Basic and Applied Basic Research Foundation of Guangdong Province 2021A1515010083Key-Area Research and Development Program of Guangdong Province 2018B030333001Key-Area Research and Development Program of Guangdong Province 2018B030340001National Natural Science Foundation of China U21A6005
6 · The paper itself

Abstract

purposeTo investigate the feasibility of using radiomics analysis of quantitative maps from synthetic MRI to preoperatively predict diffuse glioma grades, isocitrate dehydrogenase (IDH) subtypes, and 1p/19q codeletion status.

methodsData from 124 patients with diffuse glioma were used for analysis (n = 87 for training, n = 37 for testing). Quantitative T1, T2, and proton density (PD) maps were obtained using synthetic MRI. Enhancing tumour (ET), non-enhancing tumour and necrosis (NET), and peritumoral edema (PE) regions were segmented followed by manual fine-tuning. Features were extracted using PyRadiomics and then selected using Levene/T, BorutaShap and maximum relevance minimum redundancy algorithms. A support vector machine was adopted for classification. Receiver operating characteristic curve analysis and integrated discrimination improvement analysis were implemented to compare the performance of different radiomics models.

resultsRadiomics models constructed using features from multiple tumour subregions (ET + NET + PE) in the combined maps (T1 + T2 + PD) achieved the highest AUC in all three prediction tasks, among which the AUC for differentiating lower-grade and high-grade diffuse gliomas, predicting IDH mutation status and predicting 1p/19q codeletion status were 0.92, 0.95 and 0.86 respectively. Compared with those constructed on individual T1, T2, and PD maps, the discriminant ability of radiomics models constructed on the combined maps separately increased by 11, 17 and 10% in predicting glioma grades, 35, 52 and 19% in predicting IDH mutation status, and 16, 15 and 14% in predicting 1p/19q codeletion status (p < 0.05).

conclusionRadiomics analysis of quantitative maps from synthetic MRI provides a new quantitative imaging tool for the preoperative prediction of grades and molecular subtypes in diffuse gliomas.

Indexed as

Brain NeoplasmsGliomaMagnetic Resonance ImagingNeoplasm GradingAdultAgedAlgorithmsFeasibility StudiesFemaleHumansImage Interpretation, Computer-AssistedIsocitrate DehydrogenaseMaleMiddle AgedPredictive Value of TestsRadiomicsIsocitrate DehydrogenaseGlioma gradesGlioma molecular subtypesQuantitative mapsRadiomicsSynthetic MRI

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.